GSK poaches Merck KGaA exec to replace departing U.S. pharma president Bailey
admin 12th August 2019 Uncategorised 0GlaxoSmithKline has seen plenty of changes across its executive ranks over the last couple of years as CEO Emma Walmsley took the helm, but they’re still coming. Monday, the company said Jack Bailey, its U.S. pharma president, would step down.
More: GSK poaches Merck KGaA exec to replace departing U.S. pharma president Bailey
Source: fierce